Posts Tagged ‘pharmaceutical’
Drug company promotion negatively affects how doctors prescribe: Insights from a new Cochrane review
Friday, October 9th, 2026
… pharmaceutical promotion must be addressed as a commercial determinant of health — a key pathway through which corporations negatively impact public health… The medical community and governments can no longer ignore the consequences of the promotion of medicines on prescribing. It is time for strong concrete action to be taken to put an end to the way that companies are allowed to influence doctors.
Tags: Health, jurisdiction, pharmaceutical
Posted in Health Debates | 1 Comment »
The predictable consequence to the gaps in our health funding? Private spending keeps growing faster than public
Tuesday, August 18th, 2026
Bilateral “Aging With Dignity“ agreements have earmarked funding for home, community and long-term care, allowing for valuable investments in capacity, staff wages and infrastructure. But public coverage to directly displace household spending is nowhere to be found… This fragmentation carries with it significant costs, including duplicated administration across thousands of private insurers, weaker collective bargaining power over drug prices and coverage gaps that push some patients toward hospitalization when they can’t afford medication.
Tags: budget, featured, Health, ideology, jurisdiction, participation, pharmaceutical, standard of living
Posted in Health Policy Context | 1 Comment »
When politicians tell us health-care spending is unsustainable, they never seem to mention this
Monday, August 17th, 2026
… the single largest private-spending category in Canada is prescription drugs. We remain the only high-income country in the world whose universal healthcare system lacks a universal drug plan…. the notion that our health-care system is at risk because governments are spending too much is misleading in a country where seniors cover the cost of long-term care beds, parents pay out of pocket for their children’s dental work and patients spend too much on the medications they need to be healthy.
Tags: budget, Health, ideology, jurisdiction, pharmaceutical, standard of living
Posted in Health Debates | 4 Comments »
Government expects $140M in savings this year with refugee health care co-pay
Friday, May 8th, 2026
Claimants will cover a $4 fee for prescriptions and cover 30 per cent of the cost for services not typically covered by the public health care system… co-pays are expected to cover about $140 million in 2026-27, including $92.9 million in savings from dental care alone… Another $10.6 million is expected to be saved on prescriptions, $6.2 million from vision care, and $16.7 million from counselling… Routine doctor visits, emergency medicine, vaccines, hospital stays and lab work continue to be fully covered by the program.
Tags: budget, Health, immigration, jurisdiction, pharmaceutical
Posted in Inclusion Policy Context | 12 Comments »
Ford government to end funding for supervised consumption sites, advocates say — including two in Toronto
Thursday, March 19th, 2026
… the province is providing the sites 90 days’ notice “in order to support an orderly transition for clients so they can access other community health services… The sites are being asked to provide a plan for how they will transition clients to other community health services and realign their services to promote rehabilitation.
Tags: ideology, jurisdiction, mental Health, pharmaceutical
Posted in Health Delivery System | 17 Comments »
Why Ontario’s measles outbreak highlights our need for a vaccine registry
Thursday, February 12th, 2026
Ontario’s measles outbreak has laid bare how vulnerable we are without the essential tools needed to know who is protected and who is not…The solution is clear — and it’s not a crumpled yellow vaccine card. Ontarians need… a comprehensive immunization registry… a secure, province-wide system that’s accessible from family doctors’ offices to ERs across the province.
Tags: Health, jurisdiction, participation, pharmaceutical, standard of living, youth
Posted in Health Policy Context | No Comments »
Feds revive bill to build digitally connected health data systems for patients, providers
Thursday, February 5th, 2026
Canada’s health data system is “fragmented and siloed” and incomplete health records can compromise patient care and safety… If passed, the legislation would establish standards that companies developing electronic medical records must follow, allowing data to be shareable between health-care providers and across provinces and territories… “Canada’s diversity and single-payer model has created one of the most valuable health data sets on Earth,”
Tags: Health, jurisdiction, mental Health, pharmaceutical
Posted in Health Policy Context | No Comments »
Why drug approval in Canada should not rely on foreign regulators
Friday, January 30th, 2026
So far, there is no evidence to back up the claim that using decisions made by foreign drug regulators will lead to faster access to newer and better drugs. Before Canada proceeds down this pathway, Health Canada needs to show that it will improve public health.
Tags: Health, jurisdiction, pharmaceutical
Posted in Health Policy Context | 1 Comment »
4 things you need to know about health care in the federal budget
Monday, December 8th, 2025
Nearly $400 million in cuts to health… No plan to expand pharmacare… $5 billion for buildings – but no plan for health care workers… Cuts to refugee health care… “The affordability crisis is worsening, and Canadians need to know health care will be there when they need it most.
Tags: budget, Health, immigration, jurisdiction, pharmaceutical
Posted in Health Debates | No Comments »
Update the Canada Health Act
Monday, November 10th, 2025
After four decades, Canadians have a clearer sense of the system’s strengths and weaknesses. And the pandemic underscored both the value of universal health care and the urgent need for modernization… many changes could be achieved through more efficient organization, not just more spending. Nurse practitioners and physician assistants can often provide high-quality primary care less expensively than physicians, while expanded roles for pharmacists or midwives could also achieve savings and relieve some of the workload falling solely to family doctors.
Tags: economy, featured, Health, jurisdiction, pharmaceutical, standard of living
Posted in Health Debates | No Comments »
Recent Comments